Pathology of breast cancer metastasis and a view of metastasis to the brain

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
   PubMed Web of Science ®Google Scholar
• Momenimovahed Z, Salehiniya H. Epidemiological characteristics of and risk factors for breast cancer in the world. Breast Cancer (Dove Med Press). 2019;11:151–164.
   PubMed Web of Science ®Google Scholar
• Scully OJ, Bay B-H, Yip G, et al. Breast cancer metastasis. Cancer Genom Proteom. 2012;9(5):311–320.
   PubMed Web of Science ®Google Scholar
• Akhtar M, Haider A, Rashid S, et al. Paget’s “seed and soil” theory of cancer metastasis: an idea whose time has come. Adv Anat Pathol. 2019;26(1):69–74.
   PubMed Web of Science ®Google Scholar
• Neoplastic diseases: a treatise on tumours. By James Ewing AM, A.M., M.D., Sc.D., Professor of Pathology at Cornell University Medical College, N.Y.; Pathologist to the memorial hospital. Third edition. Royal 8vo. Pp. 1127, with 546 illustrations. 1928. Philadelphia and London: W. B. Saunders Co. Ltd. 63s. net. Br J Surg. 1928;16(61):174–175.
   Google Scholar
• Custódio-Santos T, Videira M, Brito MA. Brain metastasization of breast cancer. Biochim Biophys Acta Rev Cancer. 2017;1868(1):132–147.
   PubMed Web of Science ®Google Scholar
• Oliphant MUJ, Kong D, Zhou H, et al. Two sides of the same coin: the role of developmental pathways and pluripotency factors in normal mammary stem cells and breast cancer metastasis. J Mammary Gland Biol Neoplasia. 2020;25(2):85–102.
   PubMed Web of Science ®Google Scholar
• Weigelt B, Peterse JL, van ‘t Veer LJ. Breast cancer metastasis: markers and models. Nat Rev Cancer. 2005;5(8):591–602.
   PubMed Web of Science ®Google Scholar
• Zhou J, Chen Q, Zou Y, et al. Stem cells and cellular origins of breast cancer: updates in the rationale, controversies, and therapeutic implications. Front Oncol. 2019;9:820.
   PubMed Web of Science ®Google Scholar
• Sin WC, Lim CL. Breast cancer stem cells—from origins to targeted therapy. Stem Cell Investig. 2017;4:96.
   PubMedGoogle Scholar
• Fiorentino S, Urueña C, Lasso P, et al. Phyto-immunotherapy, a complementary therapeutic option to decrease metastasis and attack breast cancer stem cells. Front Oncol. 2020;10:1334.
   PubMed Web of Science ®Google Scholar
• Peart O. Metastatic breast cancer. Radiol Technol. 2017;88(5):519M–539M.
   PubMed Web of Science ®Google Scholar
• Wu Q, Li J, Zhu S, et al. Breast cancer subtypes predict the preferential site of distant metastases: a SEER based study. Oncotarget. 2017;8(17):27990–27996.
   PubMedGoogle Scholar
• Aurilio G, Disalvatore D, Pruneri G, et al. A meta-analysis of oestrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 discordance between primary breast cancer and metastases. Eur J Cancer. 2014;50(2):277–289.
   PubMed Web of Science ®Google Scholar
• Cummings MC, Simpson PT, Reid LE, et al. Metastatic progression of breast cancer: insights from 50 years of autopsies. J Pathol. 2014;232(1):23–31.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Network. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61–70.
   PubMed Web of Science ®Google Scholar
• Jin J, Wu X, Yin J, et al. Identification of genetic mutations in cancer: challenge and opportunity in the new era of targeted therapy. Front Oncol. 2019;9:263.
   PubMed Web of Science ®Google Scholar
• Lee JY, Park K, Lim SH, et al. Mutational profiling of brain metastasis from breast cancer: matched pair analysis of targeted sequencing between brain metastasis and primary breast cancer. Oncotarget. 2015;6(41):43731–43742.
   PubMedGoogle Scholar
• Angus L, Smid M, Wilting SM, et al. The genomic landscape of metastatic breast cancer highlights changes in mutation and signature frequencies. Nat Genet. 2019;51(10):1450–1458.
   PubMed Web of Science ®Google Scholar
• Bertucci F, Ng CKY, Patsouris A, et al. Genomic characterization of metastatic breast cancers. Nature. 2019;569(7757):560–564.
   PubMed Web of Science ®Google Scholar
• Haupt B, Ro JY, Schwartz MR. Basal-like breast carcinoma: a phenotypically distinct entity. Arch Pathol Lab Med. 2010;134(1):130–133.
   PubMed Web of Science ®Google Scholar
• Dvorkin-Gheva A, Hassell JA. Identification of a novel luminal molecular subtype of breast cancer. PLoS One. 2014;9(7):e103514.
   PubMed Web of Science ®Google Scholar
• Niemeier LA, Dabbs DJ, Beriwal S, et al. Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation. Mod Pathol. 2010;23(2):205–212.
   PubMed Web of Science ®Google Scholar
• Ishihara A, Tsuda H, Kitagawa K, et al. Morphological characteristics of basal-like subtype of breast carcinoma with special reference to cytopathological features. Breast Cancer. 2009;16(3):179–185.
   PubMed Web of Science ®Google Scholar
• Eliyatkın N, Yalçın E, Zengel B, et al. Molecular classification of breast carcinoma: from traditional, old-fashioned way to a new age, and a new way. J Breast Health. 2015;11(2):59–66.
   PubMedGoogle Scholar
• Trop I, LeBlanc SM, David J, et al. Molecular classification of infiltrating breast cancer: toward personalized therapy. Radiographics. 2014;34(5):1178–1195.
   PubMed Web of Science ®Google Scholar
• Da Silva L, Lakhani SR. Pathology of hereditary breast cancer. Mod Pathol. 2010;23 Suppl 2:S46–S51.
   PubMedGoogle Scholar
• Song Y, Barry WT, Seah DS, et al. Patterns of recurrence and metastasis in BRCA1/BRCA2-associated breast cancers. Cancer. 2020;126(2):271–280.
   PubMed Web of Science ®Google Scholar
• Robson M, Im S-A, Senkus E, et al. Olaparib for metastatic breast cancer in patients with a germline BRCA mutation. N Engl J Med. 2017;377(6):523–533.
   PubMed Web of Science ®Google Scholar
• Albiges L, André F, Balleyguier C, et al. Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases. Ann Oncol. 2005;16(11):1846–1847.
   PubMed Web of Science ®Google Scholar
• Lin NU, Claus E, Sohl J, et al. Sites of distant relapse and clinical outcomes in patients with metastatic triple-negative breast cancer: high incidence of central nervous system metastases. Cancer. 2008;113(10):2638–2645.
   PubMed Web of Science ®Google Scholar
• Hubalek M, Czech T, Müller H. Biological subtypes of triple-negative breast cancer. Breast Care (Basel). 2017;12(1):8–14.
   PubMed Web of Science ®Google Scholar
• Owens MB, Hill AD, Hopkins AM. Ductal barriers in mammary epithelium. Tissue Barriers. 2013;1(4):e25933.
   PubMedGoogle Scholar
• Sirka OK, Shamir ER, Ewald AJ. Myoepithelial cells are a dynamic barrier to epithelial dissemination. J Cell Biol. 2018;217(10):3368–3381.
   PubMed Web of Science ®Google Scholar
• Xie H-Y, Shao Z-M, Li D-Q. Tumor microenvironment: driving forces and potential therapeutic targets for breast cancer metastasis. Chin J Cancer. 2017;36(1):36.
   PubMedGoogle Scholar
• Fontebasso Y, Dubinett SM. Drug development for metastasis prevention. Crit Rev Oncog. 2015;20(5-6):449–473.
   PubMedGoogle Scholar
• Knudsen ES, Ertel A, Davicioni E, et al. Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia. Breast Cancer Res Treat. 2012;133(3):1009–1024.
   PubMed Web of Science ®Google Scholar
• Tungsukruthai S, Petpiroon N, Chanvorachote P. Molecular mechanisms of breast cancer metastasis and potential anti-metastatic compounds. Anticancer Res. 2018;38(5):2607–2618.
   PubMed Web of Science ®Google Scholar
• Guan X. Cancer metastases: challenges and opportunities. Acta Pharm Sin B. 2015;5(5):402–418.
   PubMed Web of Science ®Google Scholar
• Lv Z-D, Kong B, Li J-G, et al. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Oncol Rep. 2013;29(1):219–225.
   PubMed Web of Science ®Google Scholar
• Onder TT, Gupta PB, Mani SA, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res. 2008;68(10):3645–3654.
   PubMed Web of Science ®Google Scholar
• Saunus JM, McCart RA, Lim ZL, et al. Breast cancer brain metastases: clonal evolution in clinical context. Int J Mol Sci. 2017;18(1):152.
   PubMed Web of Science ®Google Scholar
• Xiao C, Wu C-H, Hu H-Z. LncRNA UCA1 promotes epithelial-mesenchymal transition (EMT) of breast cancer cells via enhancing Wnt/beta-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2016;20(13):2819–2824.
   PubMed Web of Science ®Google Scholar
• Wu X, Sun L, Wang X, et al. Breast cancer invasion and metastasis by mPRα through the PI3K/Akt signaling pathway. Pathol Oncol Res. 2016;22(3):471–476.
   PubMed Web of Science ®Google Scholar
• Narod SA, Sopik V. Is invasion a necessary step for metastases in breast cancer?Breast Cancer Res Treat. 2018;169(1):9–23.
   PubMed Web of Science ®Google Scholar
• Hu M, Yao J, Carroll DK, et al. Regulation of in situ to invasive breast carcinoma transition. Cancer Cell. 2008;13(5):394–406.
   PubMed Web of Science ®Google Scholar
• Vukicevic S, Kleinman HK, Luyten FP, et al. Identification of multiple active growth factors in basement membrane matrigel suggests caution in interpretation of cellular activity related to extracellular matrix components. Exp Cell Res. 1992;202(1):1–8.
   PubMed Web of Science ®Google Scholar
• Avgustinova A, Iravani M, Robertson D, et al. Tumour cell-derived Wnt7a recruits and activates fibroblasts to promote tumour aggressiveness. Nat Commun. 2016;7:10305.
   PubMed Web of Science ®Google Scholar
• Goswami S, Sahai E, Wyckoff JB, et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 2005;65(12):5278–5283.
   PubMed Web of Science ®Google Scholar
• Harney AS, Arwert EN, Entenberg D, et al. Real-time imaging reveals local, transient vascular permeability, and tumor cell intravasation stimulated by TIE2hi macrophage-derived VEGFA. Cancer Discov. 2015;5(9):932–943.
   PubMed Web of Science ®Google Scholar
• Wyckoff JB, Wang Y, Lin EY, et al. Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res. 2007;67(6):2649–2656.
   PubMed Web of Science ®Google Scholar
• Wong AD, Searson PC. Live-cell imaging of invasion and intravasation in an artificial microvessel platform. Cancer Res. 2014;74(17):4937–4945.
   PubMed Web of Science ®Google Scholar
• Khuon S, Liang L, Dettman RW, et al. Myosin light chain kinase mediates transcellular intravasation of breast cancer cells through the underlying endothelial cells: a three-dimensional FRET study. J Cell Sci. 2010;123(Pt 3):431–440.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zheng H, Zhan Y, et al. An emerging tumor invasion mechanism about the collective cell migration. Am J Transl Res. 2019;11(9):5301–5312.
   PubMed Web of Science ®Google Scholar
• Piñeiro R. Introduction - biology of breast cancer metastasis and importance of the analysis of CTCs. Adv Exp Med Biol. 2020;1220:1–10.
   PubMed Web of Science ®Google Scholar
• Aceto N, Bardia A, Miyamoto DT, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158(5):1110–1122.
   PubMed Web of Science ®Google Scholar
• Cominetti MR, Altei WF, Selistre-de-Araujo HS. Metastasis inhibition in breast cancer by targeting cancer cell extravasation. Breast Cancer (Dove Med Press). 2019;11:165–178.
   PubMed Web of Science ®Google Scholar
• Della Puppa A, Dal Pos S, Zovato S, et al. Solitary intra-ventricular brain metastasis from a breast carcinoma. J Neurooncol. 2010;97(1):123–126.
   PubMed Web of Science ®Google Scholar
• Hujanen ES, Terranova VP. Migration of tumor cells to organ-derived chemoattractants. Cancer Res. 1985;45(8):3517–3521.
   PubMed Web of Science ®Google Scholar
• Kienast Y, von Baumgarten L, Fuhrmann M, et al. Real-time imaging reveals the single steps of brain metastasis formation. Nat Med. 2010;16(1):116–122.
   PubMed Web of Science ®Google Scholar
• Lee B-C, Lee T-H, Avraham S, et al. Involvement of the chemokine receptor CXCR4 and its ligand stromal cell-derived factor 1alpha in breast cancer cell migration through human brain microvascular endothelial cells. Mol Cancer Res. 2004;2(6):327–338.
   PubMed Web of Science ®Google Scholar
• Stoletov K, Kato H, Zardouzian E, et al. Visualizing extravasation dynamics of metastatic tumor cells. J Cell Sci. 2010;123(Pt 13):2332–2341.
   PubMed Web of Science ®Google Scholar
• Kang S-A, Blache CA, Bajana S, et al. The effect of soluble E-selectin on tumor progression and metastasis. BMC Cancer. 2016;16:331.
   PubMed Web of Science ®Google Scholar
• Weis S, Cui J, Barnes L, et al. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis. J Cell Biol. 2004;167(2):223–229.
   PubMed Web of Science ®Google Scholar
• Lorger M, Felding-Habermann B. Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. Am J Pathol. 2010;176(6):2958–2971.
   PubMed Web of Science ®Google Scholar
• Krizbai IA, Gasparics Á, Nagyőszi P, et al. Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasation. PLoS One. 2015;10(3):e0119655.
   PubMed Web of Science ®Google Scholar
• Anderberg C, Cunha SI, Zhai Z, et al. Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination. J Exp Med. 2013;210(3):563–579.
   PubMed Web of Science ®Google Scholar
• Dasgupta A, Lim AR, Ghajar CM. Circulating and disseminated tumor cells: harbingers or initiators of metastasis?Mol Oncol. 2017;11(1):40–61.
   PubMed Web of Science ®Google Scholar
• Klauzinska M, Baljinnyam B, Raafat A, et al. Rspo2/Int7 regulates invasiveness and tumorigenic properties of mammary epithelial cells. J Cell Physiol. 2012;227(5):1960–1971.
   PubMed Web of Science ®Google Scholar
• Barkan D, Kleinman H, Simmons JL, et al. Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res. 2008;68(15):6241–6250.
   PubMed Web of Science ®Google Scholar
• Molnár J, Fazakas C, Haskó J, et al. Transmigration characteristics of breast cancer and melanoma cells through the brain endothelium: role of Rac and PI3K. Cell Adh Migr. 2016;10(3):269–281.
   PubMed Web of Science ®Google Scholar
• Carbonell WS, Ansorge O, Sibson N, et al. The vascular basement membrane as “soil” in brain metastasis. PLoS One. 2009;4(6):e5857.
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee JE, Yang S-H, et al. Induction of cytokines and growth factors by rapamycin in the microenvironment of brain metastases of lung cancer. Oncol Lett. 2013;5(3):953–958.
   PubMed Web of Science ®Google Scholar
• Kim S-J, Kim J-S, Park ES, et al. Astrocytes upregulate survival genes in tumor cells and induce protection from chemotherapy. Neoplasia. 2011;13(3):286–298.
   PubMed Web of Science ®Google Scholar
• Chen Q, Boire A, Jin X, et al. Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature. 2016;533(7604):493–498.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang S, Yao J, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015;527(7576):100–104.
   PubMed Web of Science ®Google Scholar
• Pukrop T, Dehghani F, Chuang H-N, et al. Microglia promote colonization of brain tissue by breast cancer cells in a Wnt-dependent way. Glia. 2010;58(12):1477–1489.
   PubMed Web of Science ®Google Scholar
• Ribeiro AL, Okamoto OK. Combined effects of pericytes in the tumor microenvironment. Stem Cells Int. 2015;2015:868475.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Ozawa Y, Kimura T, et al. Eribulin mesilate suppresses experimental metastasis of breast cancer cells by reversing phenotype from epithelial-mesenchymal transition (EMT) to mesenchymal-epithelial transition (MET) states. Br J Cancer. 2014;110(6):1497–1505.
   PubMed Web of Science ®Google Scholar
• Chao YL, Shepard CR, Wells A. Breast carcinoma cells re-express E-cadherin during mesenchymal to epithelial reverting transition. Mol Cancer. 2010;9:179.
   PubMed Web of Science ®Google Scholar
• Chao Y, Wu Q, Acquafondata M, et al. Partial mesenchymal to epithelial reverting transition in breast and prostate cancer metastases. Cancer Microenviron. 2012;5(1):19–28.
   PubMedGoogle Scholar
• Brook N, Brook E, Dharmarajan A, et al. Breast cancer bone metastases: pathogenesis and therapeutic targets. Int J Biochem Cell Biol. 2018;96:63–78.
   PubMed Web of Science ®Google Scholar
• Body J-J, Quinn G, Talbot S, et al. Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases. Crit Rev Oncol Hematol. 2017;115:67–80.
   PubMed Web of Science ®Google Scholar
• Mathis KM, Sturgeon KM, Winkels RM, et al. Bone resorption and bone metastasis risk. Med Hypotheses. 2018;118:36–41.
   PubMed Web of Science ®Google Scholar
• Altorki NK, Markowitz GJ, Gao D, et al. The lung microenvironment: an important regulator of tumour growth and metastasis. Nat Rev Cancer. 2019;19(1):9–31.
   PubMed Web of Science ®Google Scholar
• Oskarsson T, Acharyya S, Zhang XH-F, et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med. 2011;17(7):867–874.
   PubMed Web of Science ®Google Scholar
• O’Connell JT, Sugimoto H, Cooke VG, et al. VEGF-A and Tenascin-C produced by S100A4+ stromal cells are important for metastatic colonization. Proc Natl Acad Sci USA. 2011;108(38):16002–16007.
   PubMed Web of Science ®Google Scholar
• Malanchi I, Santamaria-Martínez A, Susanto E, et al. Interactions between cancer stem cells and their niche govern metastatic colonization. Nature. 2011;481(7379):85–89.
   PubMed Web of Science ®Google Scholar
• Pekarek LA, Starr BA, Toledano AY, et al. Inhibition of tumor growth by elimination of granulocytes. J Exp Med. 1995;181(1):435–440.
   PubMed Web of Science ®Google Scholar
• Yu PF, Huang Y, Han YY, et al. TNFα-activated mesenchymal stromal cells promote breast cancer metastasis by recruiting CXCR2+ neutrophils. Oncogene. 2017;36(4):482–490.
   PubMed Web of Science ®Google Scholar
• Morris VL, MacDonald IC, Koop S, et al. Early interactions of cancer cells with the microvasculature in mouse liver and muscle during hematogenous metastasis: videomicroscopic analysis. Clin Exp Metastasis. 1993;11(5):377–390.
   PubMed Web of Science ®Google Scholar
• Mook ORF, Van Marle J, Vreeling-Sindelárová H, et al. Visualization of early events in tumor formation of eGFP-transfected rat colon cancer cells in liver. Hepatology. 2003;38(2):295–304.
   PubMed Web of Science ®Google Scholar
• Ma R, Feng Y, Lin S, et al. Mechanisms involved in breast cancer liver metastasis. J Transl Med. 2015;13:64.
   PubMed Web of Science ®Google Scholar
• Vermeulen PB, Colpaert C, Salgado R, et al. Liver metastases from colorectal adenocarcinomas grow in three patterns with different angiogenesis and desmoplasia. J Pathol. 2001;195(3):336–342.
   PubMed Web of Science ®Google Scholar
• Tahara RK, Brewer TM, Theriault RL, et al. Bone ­metastasis of breast cancer. Adv Exp Med Biol. 2019;1152:105–129.
   PubMed Web of Science ®Google Scholar